The latest issue of the HPRA Drug Safety Newsletter (DSN) includes important updates to support safe and appropriate use of the following medicines:
- Ibuprofen – Review confirms small increased cardiovascular risk with daily doses at or above 2,400mg
- Codeine – Restricted use in children and adolescents for cough and cold
- Adverse reaction reporting- reminder
- EU Healthcare Professional Survey-have your say on how safety recommendations for medicines are communicated